Cargando…
Exploring the Mechanism of Astragalus propinquus Schischkin and Panax Notoginseng (A&P) Compounds in the Treatment of Renal Fibrosis and Chronic Kidney Disease Based on Integrated Network Analysis
Astragalus propinquus Schischkin and Panax notoginseng (A&P) has been widely used in clinical practice to treat chronic kidney disease (CKD) for many years and achieved a remarkable improvement of these outcomes. However, its mechanisms for ameliorating CKD are still poorly obscure. In the curre...
Autores principales: | Xiaojia, Wang, Jianchun, Li, Bingwen, Zhu, Xingcan, He, Yanmei, Deng, Li, Wang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898808/ https://www.ncbi.nlm.nih.gov/pubmed/35265144 http://dx.doi.org/10.1155/2022/2646022 |
Ejemplares similares
-
Roots of Astragalus propinquus Schischkin Regulate Transmembrane Iron Transport and Ferroptosis to Improve Cerebral Ischemia-Reperfusion Injury
por: Chen, Juan, et al.
Publicado: (2022) -
Astragalus propinquus schischkin and Salvia miltiorrhiza bunge promote angiogenesis to treat myocardial ischemia via Ang-1/Tie-2/FAK pathway
por: Zhang, Mu-Xin, et al.
Publicado: (2023) -
Investigation of the mechanism of the anti-cancer effects of Astragalus propinquus Schischkin and Pinellia pedatisecta Schott (A&P) on melanoma via network pharmacology and experimental verification
por: Wang, Fang, et al.
Publicado: (2022) -
Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis
por: Han, Jingxue, et al.
Publicado: (2022) -
Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats
por: Zhai, Ruonan, et al.
Publicado: (2019)